Symvivo Announcing Research Collaboration with Merck
Symvivo Corporation, a clinical-stage biotechnology company advancing a proprietary bacTRL™ gene delivery platform, announced today that it has entered into a research collaboration with Merck, known as MSD outside the… Read More



